Most Popular Angioplasty Web Site
Stent Center Stent Center
with support from Medtronic Cardiovascular
Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit

related stories:
Drug-Eluting Stent Center

external sites:
Medtronic, Inc.

May 18, 2009 -- Minneapolis -- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray PCR Post-Op Summit on Friday, May 22, 2009, in London.

Scott R. Ward
Scott Ward, President,
CardioVascular Medtronic

Scott Ward, president of the CardioVascular business and senior vice president at Medtronic, will speak to the attendees of the conference at 8 a.m. British Summer Time (2 a.m. Central Daylight Time). Ward will provide remarks highlighting Medtronic’s activities and product news from the EuroPCR conference.

A live audio webcast of the presentation will be available to all interested parties at Medtronic’s Investor Relations website at

About Medtronic
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Source: Medtronic, Inc.